FGF2 and chronic obstructive pulmonary disease: Consistently, the airway administration of FGF-2, another member of FGF family promoting tissue repair, was reported to reduce emphysema and to enhance lung repair in cigarette smoke-exposed or elastase-induced COPD mouse models, possibly by attenuating inflammation and alveolar cell death [44].